These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23542129)

  • 21. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
    Chen Y; Wright J; Meng X; Leppard KN
    Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-step colocalization of MORC3 with PML nuclear bodies.
    Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
    J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
    Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
    J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.
    Yoshida H; Ichikawa H; Tagata Y; Katsumoto T; Ohnishi K; Akao Y; Naoe T; Pandolfi PP; Kitabayashi I
    Mol Cell Biol; 2007 Aug; 27(16):5819-34. PubMed ID: 17562868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical and functional link of the leukemia-associated factors AML1 and PML.
    Nguyen LA; Pandolfi PP; Aikawa Y; Tagata Y; Ohki M; Kitabayashi I
    Blood; 2005 Jan; 105(1):292-300. PubMed ID: 15331439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic PML function in TGF-beta signalling.
    Lin HK; Bergmann S; Pandolfi PP
    Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
    Fuchs O; Provazníková D; Peslová G
    Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies.
    Salsman J; Pinder J; Tse B; Corkery D; Dellaire G
    Exp Cell Res; 2013 Oct; 319(17):2554-65. PubMed ID: 24036361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
    Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PML3 Orchestrates the Nuclear Dynamics and Function of TIP60.
    Wu Q; Hu H; Lan J; Emenari C; Wang Z; Chang KS; Huang H; Yao X
    J Biol Chem; 2009 Mar; 284(13):8747-59. PubMed ID: 19150978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sumoylation of the novel protein hRIP{beta} is involved in replication protein A deposition in PML nuclear bodies.
    Park J; Seo T; Kim H; Choe J
    Mol Cell Biol; 2005 Sep; 25(18):8202-14. PubMed ID: 16135809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.
    Qiu JJ; Chu H; Lu X; Jiang X; Dong S
    Oncogene; 2011 Feb; 30(8):967-77. PubMed ID: 20972455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Guidez F; Howell L; Isalan M; Cebrat M; Alani RM; Ivins S; Hormaeche I; McConnell MJ; Pierce S; Cole PA; Licht J; Zelent A
    Mol Cell Biol; 2005 Jul; 25(13):5552-66. PubMed ID: 15964811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
    Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
    Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.